Sernova Corp. (TSE:SVA) insider Scott Langille bought 50,000 shares of the business’s stock in a transaction on Wednesday, April 19th. The shares were acquired at an average cost of C$0.27 per share, with a total value of C$13,500.00.

Scott Langille also recently made the following trade(s):

  • On Thursday, April 20th, Scott Langille bought 100,000 shares of Sernova Corp. stock. The shares were acquired at an average cost of C$0.27 per share, with a total value of C$27,000.00.
  • On Tuesday, April 18th, Scott Langille bought 25,000 shares of Sernova Corp. stock. The shares were acquired at an average cost of C$0.26 per share, with a total value of C$6,500.00.
  • On Monday, April 17th, Scott Langille bought 24,500 shares of Sernova Corp. stock. The shares were acquired at an average cost of C$0.26 per share, with a total value of C$6,370.00.

ILLEGAL ACTIVITY WARNING: “Sernova Corp. (SVA) Insider Scott Langille Buys 50,000 Shares” was first published by Financial Market News and is the property of of Financial Market News. If you are accessing this story on another website, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this story can be viewed at https://www.financial-market-news.com/2017/04/21/sernova-corp-sva-insider-scott-langille-buys-50000-shares.html.

Sernova Corp. Company Profile

Sinovac Biotech Ltd. (Sinovac) is a holding company. The Company is a biopharmaceutical company that focuses on the research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases, including hepatitis A, hepatitis B, seasonal influenza, Haemagglutinase5 Neuraminidase1 (H5N1) and Influenza A (H1N1) pandemic influenza and mumps.

Receive News & Ratings for Sernova Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sernova Corp. and related companies with MarketBeat.com's FREE daily email newsletter.